These mutations represent additional insight into how genes such as IGF1R, MSI2, MBD2, and ASCL1 can be aberrantly regulated in cancer, highlighting the importance of expanding the field’s view of cancer genomics to include alterations in UTRs. Here, MBD2 is linked to cancer.